Elderly patients with dementia-related psychosis treated
with antipsychotic drugs are at an increased risk of death.
Quetiapine is not approved for the treatment of patients with dementia-related psychosis.
- TRADE NAME: Seroquel (AstraZeneca)
- INDICATIONS: Schizophrenia, bipolar I disorder
- CLASS: Antipsychotic, Antipsychotic, atypical, Mood stabilizer
- HALF-LIFE: ~6 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Amoxapine, Antihypertensive agents, Arsenic, Atazanavir, Azithromycin, CNS acting drugs, Darunavir, Dolasetron, Dopamine, Drugs known to cause electrolyte imbalance or increase QT interval, Erythromycin, Fluconazole, Hepatic enzyme inducers, Itraconazole, Ketoconazole, Levodopa, Methadone, P4503A inhibitors, Pazopanib, Telavancin, Tipranavir, Tricyclic antidepressants, Voriconazole
- See adverse reactions attributed to class:
INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDALITY AND ANTIDEPRESSANT DRUGS
See full prescribing information for complete boxed warnings.
Please login to view the rest of this drug profile.
Page last updated 02/24/2025
